Jirka Taylor

The Cost of Non-Europe in the area of Organised Crime and Corruption: Annex II - Corruption

Corruption is a phenomenon with significant negative consequences for the EU and its Member States. This research paper uses a mix of methodologies to quantify the overall costs of corruption in the EU in economic, social and political terms. The findings, based on new analysis, suggest that corruption costs the EU between €179bn and €990bn in GDP terms on an annual basis. Current anti-corruption measures relevant to Member States and the EU as a whole are described and their effectiveness in reducing the levels of, and opportunities for, corruption are assessed. Eight potential areas for EU action are identified that might address the barriers to the effectiveness of current measures. The costs of non-Europe are calculated in relation to two of these, as well as in relation to the implementation of recently created EU laws. 1 Wouter van Ballegooij, Thomas Zandstra, Organised Crime and Corruption: Cost of Non-Europe Report, PE 558.779, European Added Value Unit, March 2016. Annex II: Corruption PE 579.319 3 AUTHORS This study has been written by Marco Hafner, Jirka Taylor, Emma Disley, Sonja Thebes, Matteo Barberi and Martin Stepanek at RAND Europe and by Professor Mike Levi at the request of the European Added Value Unit of the Directorate for Impact Assessment and European Added Value within the Directorate General for Parliamentary Research Services (DG EPRS) of the General Secretariat of the European Parliament. This report has been peer-reviewed in accordance with RAND’s quality assurance standards. RESPONSIBLE ADMINISTRATORS Wouter van Ballegooij and Thomas Zandstra, European Added Value Unit To contact the Unit, please email: EPRS-EuropeanAddedValue@ep.europa.eu LINGUISTIC VERSIONS Original: EN DISCLAIMER The opinions expressed in this document are the sole responsibility of the author and do not necessarily represent the official position of the European Parliament. Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the publisher is given prior notice and sent a copy. Manuscript completed in March 2016. Brussels

The impact of the National Minimum Wage on employment: A meta-analysis

This report includes the findings from a meta-analysis of the empirical UK national minimum wage literature. Similar to a previous UK minimum wage study by de Linde Leonard et al. (2014), this study finds no statistically significant aggregate adverse employment effect of the NMW and also no publication bias in the NMW literature. However, estimates for different sub-groups suggest some relative larger adverse employment effects for some labour market groups like part-time employees.

Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and Final Evaluation of the Action Plan on Drugs 2013-2016: Final report

: The aim of the EU Drugs Strategy 2013-2020 is to contribute to a reduction in drug demand and drug supply within the EU. The Strategy has so far been implemented by an Action Plan covering the period 2013-2016. This article sets out the findings of an evaluation that assesses the degree of implementation of the Strategy and the Action Plan in terms of outputs and, where possible, impacts. It looks at the extent to which the objectives of the Strategy have been achieved. The evaluation aims to provide evidence to support the European Commissions decision about whether to propose a new Action Plan for the period 2017-2020 and, if so, what changes would be needed compared to the current plan. Through applying a mixed-methods approach, the evaluation examined the effectiveness, efficiency, relevance and coherence of the actions undertaken on the basis of the EU Drugs Strategy and the Action Plan, as well as their EU added value. The evaluation makes 20 recommendations, addressed to the European Commission, Member States, the European Council and other stakeholders. The key recommendation for the Commission is that a new Action Plan should be implemented for the period 2017-2020. This should be an updated version of the current Action Plan, rather than taking a new approach or introducing more new actions.

The return of investment for preventive healthcare programmes: A calculation framework for GSK's Partnership for Prevention (P4P)

................................................................................................................................................... iii Table of

Review of Six DFID-funded Growth Research Programmes: Main report

To foster economic research on growth in poor and developing countries the Department for International Development in the UK has provided funding to several organisations focused on economic growth research. Of interest for this study were six individual programmes. The aim of this review was to compare the six programmes over time, against each other, and against relevant benchmarks to capture their performance to date.

Testing the Connection Between Social Spending and Better Health

T he United States spends much more on health care than other wealthy countries— but its people fare worse in many ways. Why the disconnect? New RAND research strengthens the link between social programs and better health. It also may give policymakers reason to rethink spending priorities.